CIK 0001661181 · Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | Freedman Lori Chief Admin. and Legal Officer | Grant or award · Stock Option (Right to Buy) | +115,812 | 115,812 | ||
| 2026-02-18 | Cavorsi Robert Vice President, Strategy | Grant or award | +93,750 | 265,257 | ||
| 2026-02-18 | Cavorsi Robert Vice President, Strategy | Grant or award | +16,290 | 281,547 | ||
| 2026-02-18 | Cavorsi Robert Vice President, Strategy | Shares withheld for taxes | −5,432 | $3.84 | $21K | 276,115 |
| 2026-02-18 | Cavorsi Robert Vice President, Strategy | Grant or award · Stock Option (Right to Buy) | +53,452 | 53,452 | ||
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award | +195,312 | 701,959 | ||
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award | +43,602 | 745,561 | ||
| 2026-02-18 | Francisco David Chief Financial Officer | Shares withheld for taxes | −14,541 | $3.84 | $56K | 731,020 |
| 2026-02-18 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +111,358 | 111,358 | ||
| 2026-02-18 | Grow Brian Chief Commercial Officer | Grant or award | +234,375 | 862,793 | ||
| 2026-02-18 | Grow Brian Chief Commercial Officer | Grant or award | +48,330 | 911,123 | ||
| 2026-02-18 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −11,768 | $3.84 | $45K | 899,355 |
| 2026-02-18 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +133,630 | 133,630 | ||
| 2026-02-18 | Bilbo Patrick Chief Operating Officer | Grant or award | +210,937 | 1,095,585 | ||
| 2026-02-18 | Bilbo Patrick Chief Operating Officer | Grant or award | +48,612 | 1,144,197 | ||
| 2026-02-18 | Bilbo Patrick Chief Operating Officer | Shares withheld for taxes | −16,212 | $3.84 | $62K | 1,127,985 |
| 2026-02-18 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +120,267 | 120,267 | ||
| 2026-02-18 | Gillheeney Gary S. President and CEO | Grant or award | +890,625 | 4,134,542 | ||
| 2026-02-18 | Gillheeney Gary S. President and CEO | Grant or award | +186,968 | 4,321,510 | ||
| 2026-02-18 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −90,398 | $3.84 | $347K | 4,231,112 |
Page 2 of 12 · 228 trades